In its calculus behind its 2021 Kindred at Home deal, Humana Inc. (NYSE: HUM) had to weigh the potential cost savings and lucrative hospice divestiture against the labor pressures in the space, as well as the complexity of scaling home-based care in a fragmented industry. Last year, Humana acquired total ownership of Kindred at Home […]
This year was transformational for the hospice space. The industry took its first steps towards value-based payment through the hospice component of the value-based insurance design model, or Medicare Advantage hospice carve-in. Providers also saw an overhaul of the U.S. Centers for Medicare & Medicaid Services’ (CMS) survey process, all while contending with COVID-19 headwinds […]
Despite facing forceful pandemic-related headwinds from COVID-19, mergers and acquisitions and organic growth are fueling market share growth among the organizations listed in the LexisNexis 2020 Top Hospice Providers report. VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHE), led the charge as the largest hospice provider in the United States last year, with 4.42% […]
Though the hospice space remains fragmented, mergers and acquisitions are driving up market share, particularly for large providers. Along with service diversification and application of emerging technologies, M&A is helping to drive growth among the organizations named in LexisNexis Top 100 Hospices of 2019. With 4.5% of market share, VITAS Healthcare, a subsidiary of Chemed […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
